International Clinical Trial: Bevacizumab Combined with Immunochemotherapy versus Immunochemotherapy Alone as First-Line Treatment for HIV-Positive Patients with Stage IV Driver Gene-Negative Non-Small Cell Lung Cancer: A Multicenter, Bidirectional Cohort Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131724) titled 'Bevacizumab Combined with Immunochemotherapy versus Immunochemotherapy Alone as First-Line Treatment for HIV-Positive Patients with Stage IV Driver Gene-Negative Non-Small Cell Lung Cancer: A Multicenter, Bidirectional Cohort Study' on Sept. 6.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Nanfang Hospital, Southern Medical University

Condition: HIV Infection with Stage IV Driver Gene-Negative Non-Squamous Non-Small Cell Lung Cancer

Intervention: ICI + platinum-free regimen + bevacizumab group:None ICI + platinum-containing regimen group:None

Recruitment Status: Not Recruiti...